Inhibition of tissue repair by spironolactone: Role of mineralocorticoids in fibrous tissue formation

Molecular and Cellular Biochemistry

Volumn 189, Issue 1-2, 1998, Pages 47-54

  Slight, Simon H ^a,b   Chilakamarri, Vijay K ^a   Nasr, Samer ^a   Dhalla, Arvinder K ^a   Ramires, Felix J A ^a   Sun, Yao ^a   Ganjam, Venkataseshu K ^b   Weber, Karl T ^a  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Mineralocorticoids; Skin pouch; Spironolactone; Tissue repair

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; COLLAGEN; CROTON OIL; HYDROXYPROLINE; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR; PHORBOL ESTER; SPIRONOLACTONE;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROSIS; MALE; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; TISSUE REPAIR;

ANIMALIA; CROTON;

EID: 0031733245     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1006844010371     Document Type: Article

References (40)

1. Selye H: Use of 'granulomapouch' technic in the study of antiphlogistic corticoids. Proc Soc Exp Biol Med 82: 328-333, 1953
2. Selye H: On the mechanism through which hydrocortisone affects the resistance of tissues to injury. JAMA 152: 1207-1213, 1953
3. Selye H: Interactions between systemic and local stress. Br Med J 4872: 1167-1170, 1954
4. Weber KT: Glucocorticoids and mineralocorticoids: Antifibrotic and profibrotic components of wound healing. J Lab Clin Med 120: 22-29, 1992
5. Taubenhaus M, Amromin G: The effects of the hypophysis, thyroid, sex steroids, and the adrenal cortex upon granulation tissue. J Lab Clin Med 36: 7-18, 1950
6. Tmavsky K, Tmavska Z, Laparova V: Biochemical changes occurring during the development of a turpentine granuloma. Experientia 7: 320-321, 1961
7. Schiller E: The influence of hormones on the development of silicotic nodules produced by intraperitoneal injection of quartz. Br J Ind Med 10: 1-8, 1953
8. Rosen H, Blumenthal A, McCallum J: Effect of Asiaticoside on wound healing in the rat. Proc Soc Exp Biol Med 125: 279-280, 1967
9. Salgado E, Selye H: The role of the adrenals in the production of cardiovascular and renal changes by methylandrostenediol. Arch Int Physiol 62: 352-358, 1954
10. Weber KT: Hormones and fibrosis: A case for lost reciprocal regulation. News Physiol Sci 9: 123-128, 1994
11. Hall CE, Hall O: Hypertension and hypersalimentation. 1. Aldosterone hypertension. Lab Invest 14: 285-294, 1965
12. Brilla CG, Weber KT: Reactive and reparative myocardial fibrosis in arterial hypertension in the rat. Cardiovasc Res 26: 671-677, 1992
13. Brilla CG, Weber KT: Mineralocorticoid excess, dietary sodium and myocardial fibrosis. J Lab Clin Med 120: 893-901, 1992
14. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT: Remodeling of the rat right and left ventricle in experimental hypertension. Circ Res 67: 1355-1364, 1990
15. Young M, Fullerton M, Dilley R, Funder J: Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest 93: 2578-2583, 1994
16. Young M, Head G, Funder J: Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am J Physiol 269: E657-E662, 1995
17. Young M: Adrenal steroids and cardiac fibrosis. Steroids 60: 133-136, 1995
18. Robert V, Van Thiem N, Cheav SL, Mouas C, Swyngliedauw B, Delcayre C: Increased cardiac types I and III collagen m RNAs in aldosterone-salt hypertension. Hypertension 24: 30-36, 1994
19. Brilla CG, Zhou G, Matsubara L, Weber KT: Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone. J Mol Cell Cardiol 26: 809-820, 1994
20. Zhou G, Kandala JC, Tyagi SC, Katwa LC, Weber KT: Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts. Mol Cell Biochem 154: 171-178, 1996
21. Takeda Y, Miyamori I, Yoneda T, Iki K, Hatakeyama H, Blair IA, Hsieh F-Y, Takeda R: Synthesis of corticosterone in the vascular wall. Endocrinology 135: 2283-2286, 1994
22. Hatakeyama H, Miyamori I, Fujita T, Takeda Y, Takeda R, Yamamoto H: Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem 269: 24316-24320, 1994
23. Funder JW, Pearce PT, Smith R, Smith AI: Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated. Science 242: 583-585, 1988
24. Jenkins JS, Meakin JW, Nelson DH, Thorn GW: Inhibition of adrenal steroid 11-oxygenation in the dog. Science 128: 478-480, 1958
25. Randhawa AK, Singal PK: Pressure overload-induced cardiac hypertrophy with and without dilation. J Am Coll Cardiol 20: 1569-1575, 1992.
26. Neuman RE, Logan MA: The determination of hydroxyproline. J Biol Chem 184: 299-306, 1950
27. +-dependent 11β-hydroxysteroid dehydrogenase in the human heart. J Mol Cell Cardiol 28: 781-787, 1996
28. Mishra NC, Estensen RD, Abdel-Monem MM: Isolation and purification of phorbol from croton oil by reversed-phase column chromatography. J Chromatogr 369: 435-439, 1986
29. Sun Y, Ratajska A, Zhou G, Weber KT: Angiotensin converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone. J Lab Clin Med 122: 395-403, 1993
30. Taubenhaus M, Amromin GD: Influence of steroid hormones on granulation tissue. Endocrinology 44: 359-367, 1949
31. Atkinson RM, Jenkins L, Tomich EG, Woollett EA: The effects of some anti-inflammatory substances on carrageenin-induced granulomata. J Endocrinol 25: 87-93, 1962
32. Ashford A, Penn GB: Effect of adrenalectomy on cotton pellet granuloma formation in the rat. J Pharm Pharmacol 17: 10-14, 1965
33. Krozowski ZS, Funder JS: Renal mineralocortocoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci USA 80: 6056-6060, 1983
34. Monder C, White PC: 11β-hydroxysteroid dehydrogenase. Vit Horm 47: 187-271, 1993
35. Jamieson PM, Chapman KE, Edwards CRW, Seckl JR: 11β-hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultures of rat hepatocytes: Effect of physico chemical and hormonal manipulations. Endocrinology 136: 4754-4761, 1995
36. Slight S, Ganjam VK, Nonneman DJ, Weber KT: Glucocorticoid metabolism in the cardiac interstitium: 11β-hydroxysteroid dehydrogenase activity in cardiac fibroblasts. J Lab Clin Med 122: 180-187, 1993
37. Hammami MM, Siiteri PK: Regulation of 11β-hydroxysteroid dehydrogenase activity in human skin fibroblasts: Enzymatic modulation of glucocorticoid action. J Clin Endocrinol Metab 73: 326-334, 1991
38. Klauber N, Browne F, Anand-Apte B, D'Amato RJ: New activity of spironolactone. Inhibition of angiogenesis in vitro and in vivo. Circulation 94: 2566-2571, 1996
39. Crum R, Szabo S, Folkman J: A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 230: 1375-1378, 1985
40. Folkman J, Weisz PB, Joulli, MM, Li WW, Ewing WR: Control of angiogenesis with synthetic heparin substitutes. Science 243: 1490-1493, 1989